Figure 4
Cost-Effectiveness Acceptability curves of PCV13 vs. PCV10 vs. no vaccine to prevent pneumococcal diseases in a cohort of Colombian children, 2014.
Figure 4 | Cost Effectiveness and Resource Allocation
Cost-Effectiveness Acceptability curves of PCV13 vs. PCV10 vs. no vaccine to prevent pneumococcal diseases in a cohort of Colombian children, 2014.